Skip to content

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

Arfinn Med, the first clinician-based medical professional and patient efficacy portal for medical cannabis treatments, is now open for registrations from licensed medical professionals. The free collaborative portal allows medical professionals to register, share, research and communicate HIPAA-compliant benchmark data for medical cannabis treatments. As a free tool for physicians, Arfinn Med offers a new way to enhance treatment plans and practices in an emerging industry.  

Arfinn Med reports screen

The free portal includes four key components:

Reports – generate a report or submit your own patient findings on treatment effectiveness, daily dosage, delivery method and more, specific to patient demographics

Community – connect with a national network of peers and join specialized groups and forums for real-time discussion regarding best practices

Industry News – access news, trends and announcements impacting the medical marijuana industry and physicians’ practices

Resources – tap into assets, such as patient engagement tools that allow physicians to more closely communicate with and monitor treatment progress, and receive discounts for telemedicine software and other products to help your practice grow

Any licensed medical professional is invited to register for the portal for free, regardless of state location and medical marijuana legalization. Additional benefits of registration include: enhanced visibility of your practice through inclusion in our Participating Physicians Directory, and access to medical marijuana patient informational videos to display in your office or waiting room.

If you’re ready to join a nationwide network of licensed medical professionals to learn and share best practices and treatment efficacies for medical marijuana, join Arfinn Med for free today.

Stories you may be interested in

States with medical marijuana laws saw 20 percent drop in some opioid prescriptions

States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana programs, according to a first-of-its-kind study out of Columbia University’s Irving Medical Center. Authors said the findings underscore the importance of providing patients with pain management alternatives, such as cannabis, in efforts to reduce…
Read More →

Norfolk research company plans clinical trials using medical marijuana

Eighteen months after receiving a broad federal license for importing medical cannabis, a Norfolk research company is about to embark on a series of critical studies into a variety of medical and mental disorders, diseases and conditions. Sanyal Biotechnology is already considering proposals for research campuses and planning its first clinical trial for this summer.…
Read More →

Survey of oncologists finds knowledge gap on medical marijuana

As more states legalize medical marijuana, two key groups — researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users — are struggling to catch up with policymakers. Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial…
Read More →

Insomnia: A Silent Epidemic

The struggle to get a good night’s sleep is something many adults can relate to, but what if there was a natural alternative to keep those sheep jumping all night long? CBD, also known as cannabidiol, has been gaining popularity among patients to help treat pain, anxiety and so much more. Additionally, conditions such as…
Read More →

Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness

When we released “Weed” in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.It’s…
Read More →

Arfinn Med Patient Site

We get a lot of interest from patients asking about efficacy data for medical marijuana on a number of conditions. Though we are primarily an electronic medical record (EMR) company focussing on the cannabis industry and other complimentary or alternative therapies, our primary focus is better quality care for patients. So with that being said,…
Read More →